LOUISVILLE, Ky., Jan. 09, 2017 -- Almost Family, Inc. (NASDAQ:AFAM), a leading national provider of home healthcare services, announced today that Steve Guenthner, President, will participate in the 35th Annual J.P. Morgan Healthcare Conference which takes place January 9-12, 2017 in San Francisco, California. The Company presentation will be Thursday, January 12, 2017 at 7:30 a.m. Pacific Time/10:30 a.m. Eastern Time.
The live broadcast and replay of Almost Family’s presentation will be available under the Investors section of the Company’s website at http://www.almostfamily.com and at http://jpmorgan.metameetings.com/confbook/healthcare17/directlink?p=22883.
About Almost Family, Inc.
Almost Family, Inc., founded in 1976, is a leading national provider of home healthcare services, with 340 branch locations in 26 states, following the completion of its joint venture transaction with Community Health Systems, Inc. (CHS) (NYSE:CYH). Almost Family, Inc. and its subsidiaries operate a Medicare-certified segment, a personal care segment and a HealthCare Innovations segment. CHS Home Health is one of the nation’s larger Medicare home health care providers with 74 home health and 15 hospice locations in 22 states. Most of its home health and hospice operations are affiliated with CHS general acute care hospitals in communities across the country. The JV is managed by Almost Family, governed by a board with proportionate representation from Almost Family and CHS and is primarily focused on serving the postacute home health needs of the current CHS locations while also developing additional home health capabilities in communities with a CHS hospital but no affiliated home health care.
Almost Family, Inc. Steve Guenthner (502) 891-1000


Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Apple Turns 50: From Garage Startup to AI Crossroads
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026 



